[News1] C&R Research maintains solid clinical performance, driving a steady rise in sales
C&R Research, a Clinical Research Organization (CRO), will achieve sales of 61.9 billion KRW this year, marking a 12.3% increase…
C&R Research, a Clinical Research Organization (CRO), will achieve sales of 61.9 billion KRW this year, marking a 12.3% increase…
C&R Research signed a contract to conduct a Phase 1b clinical trial for an immuno-oncology drug candidate, commissioned by Trutino…
C&R Research (CEO Moon-Tae Yoon), CLOP (Co-CEOs Sang-Jun Park and Hyun-Jun Kim), and Trial Informatics (Co-CEOs Kyung-Won Kim and Byung-In…
C&R Research is, without a doubt, the top Contract Research Organization (CRO) in Korea. In terms of revenue, operating profit,…
C&R Research, C&R SMO, and Wonkwang University Dental Hospital signed an MOU to ‘Strengthen Clinical Trials Research Cooperation’. Through this…
C&R Research successfully received approval from the MFDS (Ministry of Food and Drug Safety of the Republic of Korea) for…
"Anyone who has used 'imtrial' even once will feel its convenience throughout the entire process of clinical trials and research,…
C&R Research is hosting the '2024 C&R imagineer' conference on September 12th at Lotte World Tower in Seoul, under the…
C&R Research recorded sales of 29 Billion KRW and an operating profit of 1.8 Billion KRW in the first half…
Establishing a new Project HQ and appointed Misook Hyun as Vice President and CPO (Chief Project Officer). She has…